Van Peer A - Search Results

1

Absorption, metabolism and excretion of ketanserin in man after oral administration.

Meuldermans W, Hendrickx J, Woestenborghs R, Van Peer A, Lauwers W, De Cree J, Heykants J. Meuldermans W, et al. Among authors: van peer a. Arzneimittelforschung. 1988 Jun;38(6):789-94. Arzneimittelforschung. 1988. PMID: 3178919

2

Excretion and biotransformation of cisapride in dogs and humans after oral administration.

Meuldermans W, Van Peer A, Hendrickx J, Lauwers W, Swysen E, Bockx M, Woestenborghs R, Heykants J. Meuldermans W, et al. Among authors: van peer a. Drug Metab Dispos. 1988 May-Jun;16(3):403-9. Drug Metab Dispos. 1988. PMID: 2900732

3

Alfentanil pharmacokinetics and metabolism in humans.

Meuldermans W, Van Peer A, Hendrickx J, Woestenborghs R, Lauwers W, Heykants J, Vanden Bussche G, Van Craeyvelt H, Van der Aa P. Meuldermans W, et al. Among authors: van craeyvelt h, van der aa p, van peer a. Anesthesiology. 1988 Oct;69(4):527-34. doi: 10.1097/00000542-198810000-00012. Anesthesiology. 1988. PMID: 3140690

4

Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole.

Van de Velde VJ, Van Peer AP, Heykants JJ, Woestenborghs RJ, Van Rooy P, De Beule KL, Cauwenbergh GF. Van de Velde VJ, et al. Among authors: van peer ap, van rooy p. Pharmacotherapy. 1996 May-Jun;16(3):424-8. Pharmacotherapy. 1996. PMID: 8726601 Clinical Trial.

5

Pharmacokinetics of oral antifungals and their clinical implications.

Heykants J, Van Peer A, Lavrijsen K, Meuldermans W, Woestenborghs R, Cauwenbergh G. Heykants J, et al. Among authors: van peer a. Br J Clin Pract Suppl. 1990 Sep;71:50-6. Br J Clin Pract Suppl. 1990. PMID: 1965419 Review.

6

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

Van Peer A, Woestenborghs R, Heykants J, Gasparini R, Gauwenbergh G. Van Peer A, et al. Eur J Clin Pharmacol. 1989;36(4):423-6. doi: 10.1007/BF00558308. Eur J Clin Pharmacol. 1989. PMID: 2544431 Clinical Trial.

7

Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol.

Van Peer A, Woestenborghs R, Embrechts L, Heykants J. Van Peer A, et al. Eur J Clin Pharmacol. 1986;31(3):339-42. doi: 10.1007/BF00981134. Eur J Clin Pharmacol. 1986. PMID: 3792431

8

Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.

Heykants J, Van Peer A, Woestenborghs R, Gould S, Mills J. Heykants J, et al. Among authors: van peer a. Eur J Clin Pharmacol. 1986;31(3):343-50. doi: 10.1007/BF00981135. Eur J Clin Pharmacol. 1986. PMID: 3792432 Clinical Trial.

9

The pharmacokinetics of risperidone in humans: a summary.

Heykants J, Huang ML, Mannens G, Meuldermans W, Snoeck E, Van Beijsterveldt L, Van Peer A, Woestenborghs R. Heykants J, et al. Among authors: van beijsterveldt l, van peer a. J Clin Psychiatry. 1994 May;55 Suppl:13-7. J Clin Psychiatry. 1994. PMID: 7520903

10

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

Huang ML, Van Peer A, Woestenborghs R, De Coster R, Heykants J, Jansen AA, Zylicz Z, Visscher HW, Jonkman JH. Huang ML, et al. Among authors: van peer a. Clin Pharmacol Ther. 1993 Sep;54(3):257-68. doi: 10.1038/clpt.1993.146. Clin Pharmacol Ther. 1993. PMID: 7690693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters